共 6 条
[1]
Oligonucleotide therapy of allergic asthma. Metzger W J,Nyce J W. The Journal of Allergy and Clinical Immunology . 1999
[2]
The immune response modifiers imiquimod and R-848 are potent activators of B lymphocytes. Tomai M A,Imbertoson L M,Stanczak T L,et al. Cellular Immunology . 2000
[3]
New directions in allergic disease: mechanismbased anti - inflammatory therapies. Barnes P J. The Journal of Allergy and Clinical Immunology . 2000
[4]
Immunomodulatory and pharmacologic properties of imiquimod. Sauder D N. Journal of the American Academy of Dermatology . 2000
[5]
Attenuation of virus- induced airway dysfunction in rats treated with imiquimod. Stokes J R,Sorkness R L,Kaplan M R,et al. European Respiratory Journal . 1998
[6]
Modulation of TH1 and TH2 cytokine production with the immune response modifiers, R-848 and imiquimod. Wegner T L,Ahonen C L,Couture A M,et al. Cellular Immunology . 1999